Slow-release hydrogel aids immunotherapy for cancer – Science Daily
Science Daily |
Slow-release hydrogel aids immunotherapy for cancer
Science Daily STINGel combines a new class of immunotherapy drugs called stimulator of interferon gene (STING) agonists with an injectable hydrogel that releases the drug in a steady dose to activate the immune system to kill cancer cells. It was developed by the … Researchers Package New Immunotherapy in Hydrogel to Better Fight Cancer |
